What is State Street SPDR S&P Pharmaceuticals ETF (XPH)?

State Street SPDR S&P Pharmaceuticals ETF (XPH) is an ETF in the Financial Services sector, Asset Management industry. View full analysis on Stocks360.

State Street SPDR S&P Pharmaceuticals ETF (XPH)

ETF analysis · AMEX · Financial Services · Asset Management

Market Cap

N/A

PE (TTM)

N/A

EPS (TTM)

N/A

Dividend Yield

N/A

Beta

0.72

Day Range

N/A

52-wk Range

N/A

Avg Volume

N/A

Volume

N/A

State Street SPDR S&P Pharmaceuticals ETF (XPH) is an exchange-traded fund in the Financial Services sector. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

You have viewed 4 SEO analysis pages

Unlock saved watchlists, personalized setups, and referral credits with a free Stocks360 account.

Continue with free signup

Proprietary Signals

Signal snapshot temporarily unavailable.

About State Street SPDR S&P Pharmaceuticals ETF

SPDR Series Trust - SPDR S&P Pharmaceuticals ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Pharmaceuticals Select Industry Index, by using representative sampling technique. SPDR Series Trust - SPDR S&P Pharmaceuticals ETF was formed on June 16, 2006 and is domiciled in the United States.